"Located in Olympia, MultiCare Capital Medical Center is a full-service, 107-bed community hospital that opened its doors in 1985. We provide a comprehensive range of medical services and deliver evidence-based care to patients throughout the South Sound, including Thurston, Mason, Lewis, and Grays Harbor counties."

During the past decade, Capital Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 22 clinical trials were completed, i.e. on average, 366.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 16 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capital Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 17 trials, followed by "National Cancer Institute (NCI)" with 15 trials sponsored, "Gynecologic Oncology Group" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "American College of Surgeons" with 2 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Capital Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Breast Cancer" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Stage IB Breast Cancer AJCC v7" (3 trials) and "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials). Many other conditions were trialed in "Capital Medical Center" in a lesser frequency.

Most popular intervention types in "Capital Medical Center" are "Drug" (35 trials), "Other" (24 trials), "Biological" (16 trials), "Radiation" (8 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (9 trials), "Paclitaxel" (6 trials), "Carboplatin" (5 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Capital Medical Center" are 24 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Capital Medical Center". undefined are not yet recruiting, 1 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Capital Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Capital Medical Center, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Capital Medical Center has several departments that took part in Clinical trials: "Covington Multicare - Oncology Clinic" - 2 trials